Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP Adherence Monitoring Using Dried Blood Spots
NCT02022657Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Apr 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of Colorado Denver. Started Apr 2014; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02022657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022657.